Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Lidocaine for Acute Pain in Surgical ICU
NCT06725485Phase 4Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Jul 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Houston Methodist Research Institute. Started Jul 2021; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06725485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725485.